Direct factory supply of certified Sophora Japonica Quercetin derivatives, liposomal powders, and high-potency wild horsetail extracts rigorously tested for New Zealand market compliance.
A technical whitepaper on botanical extraction precision, molecular purity verification, regulatory alignment with NZ MPI/Medsafe frameworks, and advanced bio-availability enhancement.
As a global leader in cGMP-certified botanical extraction, RAAG Biotech Co., Ltd. specializes in the scalable production of standardized plant extracts, high-purity monomer isolation, and supercritical solvent-free oleoresins. Serving the New Zealand dietary supplement, functional food, and veterinary care sectors, our manufacturing infrastructure bridges raw botanical sourcing with state-of-the-art column chromatography, enzymatic hydrolysis, and liposomal micro-encapsulation technology.
The modern New Zealand consumer exhibits some of the highest standards worldwide regarding clean-label transparency, non-GMO credentials, and verified biological efficacy. Consequently, B2B procurement managers require raw material partners capable of providing validated Analytical Certificates of Analysis (COAs) utilizing high-performance liquid chromatography (HPLC), ultra-violet spectroscopy (UV), and gas chromatography-mass spectrometry (GC-MS). This article outlines our technical capabilities, localized application matrix for the NZ market, and strict adherence to international quality management systems.
How top NZ nutraceutical brands integrate pure Quercetin monomers, Liposomal carriers, and Horsetail extracts into regional consumer formulations.
New Zealand's pristine ecosystems experience significant seasonal pollen spikes, driving intense demand for natural mast-cell stabilizing agents. Formulators combine our Quercetin 98% Powder (Sophora Japonica Extract) with native NZ Manuka propolis and Bioflavonoids to engineer high-potency anti-histamine and upper respiratory wellness capsules.
With an aging population in New Zealand focused on active aging, cellular rejuvenation is a primary growth sector. Our Liposomal Quercetin 50% Powder provides up to 20x higher oral bioavailability over standard powders. NZ brand owners pair this liposomal monomer with Enzogenol (pine bark extract) and NMN for cutting-edge senolytic therapy formulations.
Outdoor lifestyle culture (hiking, rugby, marathons) fuels robust demand for joint resilience. Formulators merge Wild Horsetail Herb Extract Powder (Rich in Plant Silica & Quercetin) with New Zealand Green-Lipped Mussel extract to stimulate collagen synthesis, enhance bone density, and promote joint cartilage repair.
Key drivers re-shaping botanical monomer procurement across Australasia.
New Zealand enforces stringent biosecurity import standards. Raw plant material imports are closely monitored for micro-organisms, soil contamination, and unapproved species. Direct monomer isolates—such as Quercetin Anhydrous CAS 117-39-5 purified to 98%—bypass many biosecurity risks associated with raw plant biomass because they are refined chemical substances. RAAG Biotech provides full species identification, phytosanitary declarations, and non-irradiation certificates for seamless clearance through NZ customs.
While New Zealand boasts famous native actives (Manuka, Totarol, Totara extract, Kete), local brand manufacturers increasingly recognize that combining indigenous actives with internationally validated pure monomers yields superior therapeutic marketing claims. Synergistic formulas blending standardized Sophora Japonica Quercetin with native anti-inflammatory bio-actives represent the fastest-growing SKU category in NZ pharmacy chains.
Hydrophobic botanical monomers like Quercetin traditionally suffer from low oral intestinal absorption (typically <2%). The NZ consumer base is highly educated on lipid-based delivery mechanisms. Demand for Liposomal Quercetin 50% Powder—which uses sunflower or soy lecithin phospholipids to protect active molecules through gastric passage—has grown over 140% year-on-year in premium supplement ranges across Australasia.
Environmental stewardship is central to the New Zealand brand identity ("100% Pure New Zealand"). NZ contract manufacturers reject raw materials produced with toxic chlorinated solvents or excessive carbon footprints. RAAG Biotech utilizes food-grade ethanol reflux, aqueous extraction, and Supercritical CO2 technology, leaving zero harmful solvent residues (meeting USP/EP solvent limits) and complying fully with ISO14001 environmental standards.
Comprehensive analytical data to support B2B research & development teams in selecting the optimal raw material grade.
| Specification Parameter | Quercetin Dihydrate 95%/98% | Quercetin Anhydrous 98% | Liposomal Quercetin 50% | Wild Horsetail Extract (Quercetin/Silica) |
|---|---|---|---|---|
| Botanical Source | Sophora Japonica L. (Flower) | Sophora Japonica L. (Flower) | Encapsulated Sophora Extract | Equisetum Arvense L. (Herb) |
| CAS Registration No. | 6151-25-9 | 117-39-5 | 117-39-5 (Active Core) | N/A (Complex Extract) |
| Assay (HPLC / UV) | ≥ 95.0% / ≥ 98.0% | ≥ 98.0% (Anhydrous Basis) | ≥ 50.0% Liposomal Quercetin | ≥ 7% Organic Silica / 1% Quercetin |
| Physical Appearance | Fine Yellow Powder | Fine Light Yellow Powder | Yellow to Light Amber Powder | Fine Yellowish Brown Powder |
| Water Solubility | Slightly Soluble (<0.1 g/L) | Practically Insoluble | Water-Dispersible Liposome | Water Soluble / Dispersible |
| Loss on Drying | 10.0% - 14.0% (Hydrate water) | ≤ 4.0% | ≤ 5.0% | ≤ 5.0% |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm Total (Pb ≤ 2ppm) | ≤ 10 ppm Total (Pb ≤ 2ppm) | ≤ 5 ppm Total | ≤ 10 ppm Total |
| Primary Application | Standard Capsules & Tablets | Direct Compression & Hard Shells | High-Absorbency Liquids & Premix | Bone, Hair, Nail & Joint Formulas |
Decade-long extraction engineering, robust quality documentation, and dedicated global export support.
Our manufacturing plant operates under rigorous ISO9001, ISO22000, HACCP, HALAL, KOSHER, and organic-compliant quality control systems. Every lot undergoes strict 3-tier testing before release.
We maintain contracted agricultural growing bases for Sophora Japonica and wild herbs. Internal batch codes allow finished extracts to be traced directly back to farm origin, harvest date, drying method, and extraction logs.
Every shipment comes with batch-specific COAs, MSDS, Technical Data Sheets (TDS), Allergen Statements, Non-GMO Declarations, Residual Solvent Reports, and Pesticide Panel Screenings meeting NZ regulations.
In addition to pure monomers, we run state-of-the-art Supercritical CO2 extraction lines to yield solvent-free oleoresins, protecting heat-sensitive active fractions without chemical residual contamination.
We provide tailored mesh sizes (80 mesh to 200 mesh) as well as DC-grade (Direct Compression) granular Quercetin Dihydrate/Anhydrous for high-speed tablet manufacturing without capping or sticking.
To support product development and trial batches, we offer 10g–50g free sample kits dispatched via DHL/FedEx, enabling NZ QA labs to verify purity and physical parameters prior to commercial orders.
Clear, direct technical answers for New Zealand quality assurance officers, purchasing agents, and formulation scientists.
Our pure Quercetin monomers are derived from Sophora Japonica flower buds through multi-stage ethanol extraction and column crystallization, achieving purity levels up to 98% HPLC. Because this is an isolated chemical monomer, it is free from plant pathogens or organic soil debris. Furthermore, each batch is tested via ICP-MS for heavy metals, ensuring Lead (≤2ppm), Arsenic (≤1ppm), Cadmium (≤1ppm), and Mercury (≤0.1ppm), fully satisfying the Australia New Zealand Food Standards Code (FSANZ) and MPI biosecurity regulations.
Quercetin Dihydrate (CAS 6151-25-9) contains two bound water molecules within its crystal lattice, giving it a typical loss-on-drying value of 10%–14%. It is the standard cost-effective choice for standard hard gelatin or HPMC capsules. Quercetin Anhydrous (CAS 117-39-5) has had crystal water removed, containing ≤4% moisture. Anhydrous is less prone to moisture-induced degradation in hygroscopic premixes and is ideal for direct compression tablets or moisture-sensitive formulations.
Our Liposomal Quercetin 50% Powder uses non-GMO sunflower lecithin (or optionally non-GMO soy lecithin) as the phospholipid lipid bilayer capsule. It contains no synthetic surfactants, polysorbates, or artificial preservers. This clean-label carrier system creates stable nano-emulsion vesicles when hydrated, drastically improving intestinal wall absorption—making it fully compliant with New Zealand natural clean-label branding expectations.
Our Wild Horsetail Herb Extract (Equisetum Arvense) is standardized primarily for natural organic Silica content (≥7% by gravimetric analysis) alongside natural bioflavonoids including Quercetin glycosides. Organic silica is a vital cofactor in collagen hydroxylation and matrix mineralization. When combined with calcium, Vitamin D3, or NZ Green-Lipped Mussel powder, it enhances osteoblast activity and connective tissue integrity.
For standardized extract powders and pure monomers (Quercetin 95%/98%), our standard commercial MOQ is 1 kg for trial batches and 25 kg (standard fiber drum) for production runs. In-stock ingredients ship within 3–5 business days. Air freight shipments to Auckland, Wellington, or Christchurch typically arrive within 5–7 days, while sea freight door-to-door delivery takes approximately 18–22 days.
Yes. Standard fine powder is milled to 80–100 mesh. However, for high-speed automatic capsule filling machines or direct tablet compression, we offer Granular Quercetin (40–60 mesh) which eliminates static cling, improves powder flowability, reduces dust contamination in manufacturing suites, and prevents tablet capping.
Request complete specification sheets, batch-specific Certificates of Analysis (COAs), solvent residue profiles, and free samples for your laboratory evaluation in New Zealand today.
Get Catalog